Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Enalees appoints Eric Germain as managing director

Germain will focus on group’s local and national network operations.

Enalees, a biotech company specializing in the design, production and marketing of state-of-the-art rapid molecular diagnostic tests for the veterinary profession, based on an isothermal amplification technique (LAMP PCR), has appointed Eric Germain to the position of managing director. In his new role, Germain will provide support for company president and co-founder, Laurent Thiery, as the group continues on its path of growth and global expansion.

Germain has more than 25 years’ experience in strategic and decision-making roles, which include being responsible for territorial expansion and economic development. After completing a master’s degree in biology at the Université d’Orsay in Paris, France, and spending his early career in the education sector, he went on to various roles as managing director and chief of staff within both private groups and French public institutions including Genopole. In his previous roles, he has headed teams of all sizes (from 20 to 200 staff), helped facilitate change within organizations and negotiated the construction of numerous facilities involving a wide range of stakeholders Germain has also promoted the creation of innovative businesses in the fields of genomics and the environment in the Paris area.

“We’re delighted to welcome Eric Germain to Enalees. He is exactly the kind of person that I want to have beside me. The teams will benefit from his personable and approachable personality and his 25 years' experience in operational and strategic management of numerous large-scale projects. He joins us at a key strategic moment for Enalees, as we look to build our European and global operations, while continuing our search for funds to meet the market needs and our growth ambitions," said Laurent Thiery, president and co-founder of Enalees.

In 2022, Enalees opened its first European branch, in the UK, marking the first strategic step on its roadmap to establishing a European group specialized in rapid molecular diagnostic tests for the veterinary profession. Thanks to a €500,000 ($537K) subsidy from the Île-de-France region (France), the group also expanded its R&D team and took steps to strengthen its supply and production chains.

“Several years ago, I worked with Enalees as an economic and territorial advisor. I am delighted to now be rejoining this dynamic and innovative team, to support the group’s co-founder and president, Laurent Thiery, in all aspects of the business,” Germain said.

Using his managerial experience and network of contacts to increase the visibility of the group among political decision-makers at both a local and national level, Germain said his priority is to keep Enalees on a growth trajectory. “It’s my mission to strengthen the business’ position as a leading biotechnology company in the field of animal health, thanks to our expertise with LAMP PCR technology and our lyophilization production process, which enable us to offer veterinary diagnostic kits and services for third parties.”

In 2023, Enalees plans to open a series of new branches in Europe and set up a new proteomic development & manufacturing facility at its Genopole site. Between now and 2024, the company will also continue its efforts to expand its sales team.

Enalees offers a range of simple, rapid and innovative diagnostic tests for the veterinary sector, which are designed to detect many different infectious diseases in dogs, cats and horses. Based on the company’s unique isothermal DNA amplification technique, these point-of-care tests are both highly accurate and highly sensitive. They can therefore detect the presence of a virus, parasite or bacteria at a very early stage without the need for costly and complicated equipment. Moreover, the results are ready in just 30 minutes, meaning treatment can start the very same day.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.